MX2018004274A - Metodos y composiciones para contracciones musculares no deseadas o anormales. - Google Patents
Metodos y composiciones para contracciones musculares no deseadas o anormales.Info
- Publication number
- MX2018004274A MX2018004274A MX2018004274A MX2018004274A MX2018004274A MX 2018004274 A MX2018004274 A MX 2018004274A MX 2018004274 A MX2018004274 A MX 2018004274A MX 2018004274 A MX2018004274 A MX 2018004274A MX 2018004274 A MX2018004274 A MX 2018004274A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- methods
- unwanted
- muscle contractions
- abnormal muscle
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002159 abnormal effect Effects 0.000 title 1
- 230000004118 muscle contraction Effects 0.000 title 1
- 208000007101 Muscle Cramp Diseases 0.000 abstract 2
- 208000008238 Muscle Spasticity Diseases 0.000 abstract 1
- 206010028293 Muscle contractions involuntary Diseases 0.000 abstract 1
- 208000005392 Spasm Diseases 0.000 abstract 1
- 208000010118 dystonia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La invención se refiere a métodos y composiciones para tratar calambres musculares, espasmos musculares, espasticidad muscular, distonías y fasciculaciones.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562237973P | 2015-10-06 | 2015-10-06 | |
US201662351489P | 2016-06-17 | 2016-06-17 | |
US201662370471P | 2016-08-03 | 2016-08-03 | |
PCT/US2016/055821 WO2017062665A1 (en) | 2015-10-06 | 2016-10-06 | Methods and compositions for unwanted or abnormal muscle contractions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018004274A true MX2018004274A (es) | 2018-06-22 |
Family
ID=58488538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018004274A MX2018004274A (es) | 2015-10-06 | 2016-10-06 | Metodos y composiciones para contracciones musculares no deseadas o anormales. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20180116976A1 (es) |
EP (1) | EP3359178A4 (es) |
JP (1) | JP2018533556A (es) |
KR (1) | KR20180058827A (es) |
CN (1) | CN108367041A (es) |
AU (1) | AU2016336544A1 (es) |
BR (1) | BR112018006986A2 (es) |
CA (1) | CA3001356A1 (es) |
EA (1) | EA201890884A1 (es) |
IL (1) | IL258507A (es) |
MX (1) | MX2018004274A (es) |
SG (1) | SG11201802785XA (es) |
WO (1) | WO2017062665A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018136943A1 (en) | 2017-01-23 | 2018-07-26 | Flex Pharma, Inc. | Compositions and methods affecting exercise performance |
AU2019393559A1 (en) * | 2018-12-07 | 2021-07-29 | Suntory Holdings Limited | Fruit juice beverage having improved quality of taste exhibited by sugar and sweetener |
JP7177738B2 (ja) * | 2019-03-26 | 2022-11-24 | サントリーホールディングス株式会社 | リナロール含有飲料 |
US11554155B2 (en) * | 2020-01-20 | 2023-01-17 | Advanced Health Solutions LLC | Compositions and methods for improving gastrointestinal function |
WO2024101890A1 (ko) * | 2022-11-09 | 2024-05-16 | 경희대학교 산학협력단 | 건강 추출물, 쇼가올 및 레보도파를 유효성분으로 포함하는 파킨슨병 또는 도파민 유발 이상운동증의 예방 또는 치료용 조성물 |
CN117883414B (zh) * | 2024-03-18 | 2024-06-21 | 山东第二医科大学 | 一种长效缓释辣椒素微球及其制备方法和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090304827A1 (en) * | 2008-05-08 | 2009-12-10 | Kim Darrick S H L | Combinations of Ingredients Having Synergistic Anti-Inflammatory Effects |
ES2647087T3 (es) * | 2010-07-27 | 2017-12-19 | Flex Pharma, Inc. | Métodos y composiciones para prevenir y aliviar los calambres musculares y para la recuperación de la irritabilidad neuromuscular y de la fatiga después del ejercicio |
BR112016024034A2 (pt) * | 2014-04-14 | 2017-12-26 | Flex Pharma Inc | ativadores de canal iônico e métodos de uso |
-
2016
- 2016-10-06 SG SG11201802785XA patent/SG11201802785XA/en unknown
- 2016-10-06 WO PCT/US2016/055821 patent/WO2017062665A1/en active Application Filing
- 2016-10-06 BR BR112018006986A patent/BR112018006986A2/pt not_active Application Discontinuation
- 2016-10-06 MX MX2018004274A patent/MX2018004274A/es unknown
- 2016-10-06 AU AU2016336544A patent/AU2016336544A1/en not_active Abandoned
- 2016-10-06 JP JP2018517517A patent/JP2018533556A/ja active Pending
- 2016-10-06 EP EP16854351.0A patent/EP3359178A4/en not_active Withdrawn
- 2016-10-06 EA EA201890884A patent/EA201890884A1/ru unknown
- 2016-10-06 KR KR1020187012474A patent/KR20180058827A/ko unknown
- 2016-10-06 CN CN201680071480.8A patent/CN108367041A/zh active Pending
- 2016-10-06 CA CA3001356A patent/CA3001356A1/en not_active Abandoned
-
2017
- 2017-11-21 US US15/819,881 patent/US20180116976A1/en not_active Abandoned
-
2018
- 2018-04-05 IL IL258507A patent/IL258507A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2016336544A1 (en) | 2018-04-26 |
CN108367041A (zh) | 2018-08-03 |
SG11201802785XA (en) | 2018-05-30 |
EP3359178A4 (en) | 2019-08-28 |
CA3001356A1 (en) | 2017-04-13 |
IL258507A (en) | 2018-05-31 |
US20180116976A1 (en) | 2018-05-03 |
JP2018533556A (ja) | 2018-11-15 |
WO2017062665A1 (en) | 2017-04-13 |
KR20180058827A (ko) | 2018-06-01 |
EA201890884A1 (ru) | 2018-11-30 |
EP3359178A1 (en) | 2018-08-15 |
BR112018006986A2 (pt) | 2018-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021000710A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2019003623A (es) | Composiciones y metodos para el tratamiento de afecciones oftalmicas. | |
MX2019007030A (es) | Composiciones y metodos para el tratamiento del cancer. | |
MX2018006767A (es) | Composiciones y metodos para oncologia inmunologica. | |
PH12017501999A1 (en) | K-ras modulators | |
MX2020005213A (es) | Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos. | |
MX2018005829A (es) | Composiciones para tratar el cabello. | |
MX2018008052A (es) | Inhibidores de desmetilasa especifica de lisina 1 (lsd1). | |
MX2018004274A (es) | Metodos y composiciones para contracciones musculares no deseadas o anormales. | |
NZ742742A (en) | Compositions and methods for inhibiting arginase activity | |
EP3750907A3 (en) | Raav-based compositions and methods for treating amyotrophic lateral sclerosis | |
MX2018006632A (es) | Inhibidores biciclicos de peptidilarginina deiminasa 4 (pad4). | |
SG10201808940WA (en) | Nox inhibitor and nfкb inhibitor containing methoxyflavone | |
MX2018009773A (es) | Heteroarilos inhibidores de peptidilarginina desiminasa 4 (pad4). | |
MX2018008105A (es) | Compuestos inhibidores de metaloenzima. | |
AU2019268074A1 (en) | Methods for treating hepcidin-mediated disorders | |
PH12014502704A1 (en) | Compounds and compositions for modulating egfr activity | |
MX2016003843A (es) | Inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos. | |
AU2016263598A8 (en) | Methods and kits for treating depression | |
MX2018006700A (es) | Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4). | |
MX2018000715A (es) | Metodos para tratar cancer usando apilimod. | |
EA201591278A1 (ru) | Композиции, содержащие c1-inh, и способы профилактики и лечения расстройств, ассоциированых с дефицитом ингибитора с1 эстеразы | |
MX2016009590A (es) | Composiciones de apilimod y métodos para usar las mismas. | |
PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
PH12017501864A1 (en) | Compositions and methods for treating autism |